S. Romas, M. Tang, L. Berglund, R. Mayeux, and . Apoe, APOE genotype, plasma lipids, lipoproteins, and AD in community elderly, Neurology, vol.53, issue.3, pp.517-521, 1999.
DOI : 10.1212/WNL.53.3.517

P. Elias, M. Elias, D. Agostino-'rb, L. Sullivan, and P. Wolf, Serum Cholesterol and Cognitive Performance in the Framingham Heart Study, Psychosomatic Medicine, vol.67, issue.1, pp.24-30, 2005.
DOI : 10.1097/01.psy.0000151745.67285.c2

G. Swan, A. Larue, D. Carmelli, and T. Reed, Decline in Cognitive Performance in Aging Twins, Archives of Neurology, vol.49, issue.5, pp.476-481, 1992.
DOI : 10.1001/archneur.1992.00530290058012

K. Rockwood, S. Kirkland, D. Hogan, C. Macknight, H. Merry et al., Use of Lipid-Lowering Agents, Indication Bias, and the Risk of Dementia in Community-Dwelling Elderly People, Archives of Neurology, vol.59, issue.2, pp.223-227, 2002.
DOI : 10.1001/archneur.59.2.223

G. Li, R. Higdon, W. Kukull, E. Peskind, V. Valen et al., Statin therapy and risk of dementia in the elderly: A community-based prospective cohort study, Neurology, vol.63, issue.9, pp.1624-1628, 2004.
DOI : 10.1212/01.WNL.0000142963.90204.58

M. Kivipelto and A. Solomon, Cholesterol as a risk factor for Alzheimer s disease -epidemiological evidence ', Acta Neurol Scand, vol.185, pp.50-57, 2006.

J. Saczynski, L. White, R. Peila, and B. Rodriguez, The Relation between Apolipoprotein A-I and Dementia: The Honolulu-Asia Aging Study, American Journal of Epidemiology, vol.165, issue.9, pp.985-992, 2007.
DOI : 10.1093/aje/kwm027

R. Evans, S. Hui, A. Perkins, D. Lahiri, and J. Poirier, Cholesterol and APOE genotype interact to influence Alzheimer disease progression, Neurology, vol.62, issue.10, pp.1869-1871, 2004.
DOI : 10.1212/01.WNL.0000125323.15458.3F

T. Muckle and J. Roy, HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN DIFFERENTIAL DIAGNOSIS OF SENILE DEMENTIA, The Lancet, vol.325, issue.8439, pp.1191-1193, 1985.
DOI : 10.1016/S0140-6736(85)92866-1

M. Michikawa and . Cholesterol, Cholesterol paradox: Is high total or low HDL cholesterol level a risk for Alzheimer's disease?, Journal of Neuroscience Research, vol.72, issue.2, pp.141-146, 2003.
DOI : 10.1002/jnr.10585

O. Olesen and L. Dago, High Density Lipoprotein Inhibits Assembly of Amyloid ??-Peptides into Fibrils, Biochemical and Biophysical Research Communications, vol.270, issue.1, pp.62-66, 2000.
DOI : 10.1006/bbrc.2000.2372

M. Marmot, E. Brunner, and . Profile, Cohort Profile: The Whitehall II study, International Journal of Epidemiology, vol.34, issue.2, pp.251-256, 2005.
DOI : 10.1093/ije/dyh372

H. Tunstall-pedoe, K. Kuulasmaa, P. Amouyel, D. Arveiler, and A. Rajakangas, Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents, Circulation, vol.90, issue.1, pp.583-612, 1994.
DOI : 10.1161/01.CIR.90.1.583

G. Rose, P. Hamilton, H. Keen, D. Reid, P. Mccartney et al., MYOCARDIAL ISCH??MIA, RISK FACTORS AND DEATH FROM CORONARY HEART-DISEASE, The Lancet, vol.309, issue.8003, pp.105-109, 1977.
DOI : 10.1016/S0140-6736(77)91701-9

S. Miller and D. Dykes, Polesky HF A simple salting out procedure for extracting DNA from human nucleated cells, Nucleic Acids Res, vol.16, 1998.

R. Evans, C. Emsley, S. Gao, A. Sahota, K. Hall et al., Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: A population-based study of African Americans, Neurology, vol.54, issue.1, pp.240-242, 2000.
DOI : 10.1212/WNL.54.1.240